Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

7.31
+3.1676.14%
Post-market: 5.82-1.4900-20.38%16:35 EDT
Volume:24.41M
Turnover:253.11M
Market Cap:4.00M
PE:-0.07
High:15.73
Open:4.03
Low:3.90
Close:4.15
52wk High:179.19
52wk Low:3.45
Shares:547.78K
Float Shares:547.42K
Volume Ratio:147.00
T/O Rate:4458.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4151
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.80
PE(LYR):-0.02

Loading ...

Why Is Penny Stock Artelo Biosciences (ARTL) Up Over 200% Today?

TIPRANKS
·
2 hours ago

NASDAQ Trade Halt Volatility Trading Pause at 10:54 Am

Reuters
·
Yesterday

Artelo Biosciences files new provisional patent application covering ART27.13

TIPRANKS
·
Yesterday

Artelo Biosciences Files Provisional Patent for Art27.13 Obesity Use After Mouse Study Shows up to 40% Weight Loss with Semaglutide

Reuters
·
Yesterday

Hedge Fund Veteran Daivd Einhorn Predicts Gold Will Significantly Outperform the Nasdaq Over the Next 3-5 Years

Deep News
·
Sep 18

Einhorn's Bold Call: Gold Set to Crush Nasdaq Over the Next Half-Decade

Deep News
·
Sep 18

Artelo Biosciences announces results from nonclinical study of ART27.13

TIPRANKS
·
Sep 16

Artelo Says Oral Art27.13 Matches Semaglutide Weight Loss in Obese Mice Study

Reuters
·
Sep 16

Artelo Biosciences - Art27.13 Shows no Effect on Body Weight or Fat Mass in Lean Mice

THOMSON REUTERS
·
Sep 16

Artelo Biosciences Announces Art27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

THOMSON REUTERS
·
Sep 16

Artelo Biosciences - Art27.13 Monotherapy Reduces Body Weight by 20% in Obese Mice, Matching Semaglutide

THOMSON REUTERS
·
Sep 16

Artelo Biosciences CEO Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 08

Artelo Biosciences Inc trading halted, news pending

TIPRANKS
·
Aug 29

Artelo Biosciences Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

Artelo secures Japan patent allowance for ART27.13 commercial formulation

TIPRANKS
·
Aug 20

Artelo Biosciences Wins Japan Patent Allowance for Art27.13 Commercial Formulation

Reuters
·
Aug 20

Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of Art27.13

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Art27.13 Patent Estate Issued or Allowed in US, Japan, Europe

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Receives Uspto Notice of Allowance for Art27.13 Formulation Patent

THOMSON REUTERS
·
Aug 17

Artelo Biosciences - Patent Protection for Art27.13 Expected Through 2041

THOMSON REUTERS
·
Aug 17